Drug
Palbociclib
Palbociclib: highest development phase Approved, developed by Biocon, Eisai, United Therapeutics. 3 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Biocon, Eisai, United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| PALBOCICLIB CAPSULES | Approved | |
| PALBOCICLIB | Approved | |
| Palbociclib (75, 100, 125 milligram [mg]) NCT04288089 | Phase 1 | Receptors, Estrogen |
Latest
No recent events.
Follow Palbociclib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.